Product Description
Since last many years Saintroy Lifescience is leading manufacture, export and supplier of Thiotepa for Injection from Surat, Gujarat, India. Thiotepa for Injection use in combination with other chemotherapy agents to treat cancer.
Tags: Thiotepa for Injection manufacturer, Thiotepa for Injection Exporter, Thiotepa for Injection supplier, and Thiotepa for Injection, whogmp approved Thiotepa for Injection manufacturer and supplier, Thiotepa for Injection distributor,Thiotepa for Injection shipper, Thiotepa for Injection 15 mg Thiotepa for Injection 15mg supplier, Thiotepa for Injection 15 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India.
Registration: Saintroy Lifescience is interested in registration of own brand or customer brands in ministry of health of clients country and we also provide the products samples, COA, COPP, ACT or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
About Thiotepa for InjectionThiotepa for Injection is a chemotherapy agent widely used to manage certain malignant conditions. Each 15 mg vial contains Thiotepa as the active salt composition, formulated as a lyophilized powder. Reconstitution with sterile water for injection is necessary prior to use. Designed for administration by trained healthcare professionals, this product meets stringent quality criteria and is suitable for various clinical settings, including hospitals and oncology centers.
Proper Handling and AdministrationDue to its cytotoxic properties, Thiotepa for Injection must be handled using appropriate safety measures. Only qualified medical personnel should administer this medication by injection. Prior to injection, it should be reconstituted strictly as described in the product leaflet. Comprehensive instructions for handling and administration help to safeguard both healthcare staff and patients.
Safe Storage and Shelf LifeTo maintain its effectiveness, store Thiotepa for Injection in a cool, dry place, away from direct sunlight and moisture. The product remains stable for 2 years when stored according to these guidelines. Always check the expiration date before use, and consult the leaflet for any storage-related information.
FAQ's of Thiotepa for Injection:
Q: How is Thiotepa for Injection administered?
A: Thiotepa for Injection is administered parenterally by a qualified healthcare professional. It requires reconstitution with sterile water for injection, following instructions provided in the accompanying leaflet.
Q: What conditions is Thiotepa for Injection used to treat?
A: This medication is indicated for the treatment of select cancers, primarily ovarian, breast, and bladder cancer. Your doctor will determine its suitability based on your specific diagnosis.
Q: What is the process for preparing Thiotepa for Injection before use?
A: The lyophilized powder should be reconstituted with sterile water for injection according to the instructions in the product leaflet. This step should be carried out by trained personnel observing cytotoxic handling precautions.
Q: Where should Thiotepa for Injection be stored?
A: Store the vial in a cool, dry place to preserve its stability. Make sure it remains in its original packaging until ready for use and strictly adhere to the storage instructions provided.
Q: Who is authorized to use and handle Thiotepa for Injection?
A: This medication is intended for use by qualified healthcare professionals only. Special cytotoxic handling procedures must be followed throughout preparation and administration.
Q: What are the benefits of using Thiotepa for Injection in cancer therapy?
A: Thiotepa is an established chemotherapeutic agent that helps control the growth of certain cancers, contributing to more effective treatment outcomes when used as part of a comprehensive cancer management plan.